- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
Q1 2021 Novo Nordisk A/S Earnings Call (London-Based Investors) Transcript
Hello and welcome to the Q1 2021 Novo Nordisk A/S Earnings Presentation. (Operator Instructions) Today, I'm pleased to present Karsten Munk Knudsen. Please go ahead with your meeting.
/- -
Thank you, and welcome to the Q1 results meeting for Novo Nordisk. Today with me, I have Camilla Sylvest, Head of Commercial Strategy; and Martin Lange, Head of Global Development. So before moving into our investor presentation, I'd just like to thank Keyur Parekh and Goldman Sachs for orchestrating this London lunch conference meeting. We had been looking forward to meeting you all in person as we did a year ago. And hopefully, we'll be getting closer to meeting in-person in coming quarters.
So we'll -- the process for this meeting is that we'll do a quick review of our quarterly slide deck. It'll last to the tune of 15 minutes, after which we will be moving on to a Q&A session.
So -- and as you know, the statements we
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |